ASP Isotopes Inc. ASPI
Nasdaq · XNAS · stock · Miscellaneous Chemical Products · website · IPO 2022-11-10
ASP Isotopes Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Gross margin | 14.3% | 38.6% | 32.1% | — |
| Operating margin | -251.2% | -636.0% | -3704.6% | — |
| Net margin | -670.2% | -782.4% | -3762.9% | — |
| FCF margin | -198.9% | -636.4% | -1788.3% | — |
| Return on assets | -32.1% | -34.4% | -59.2% | -39.6% |
| Return on equity | -60.8% | -63.4% | -86.5% | -50.4% |
| Debt / equity | 0.01× | 0.05× | — | — |
| Current ratio | 12.23 | 9.31 | 1.85 | 1.71 |
| Revenue growth | 475.5% | 857.0% | — | — |
Source: SEC EDGAR filings · CIK 0001921865 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.